Integrum AB (publ)

kr 8.07As of Sun 8 Nov 2026, 12:00 UTC
STO:INTEG-BHealthcare
Country Sweden
PE (Fwd) •••
TSR 9Y CAGR (8.78%)
Div yield —
ROE (20.74%)
Medical Devices
Beta (5Y) 0.48
PE TTM —
TSR TTM (3.84%)
Mkt cap kr 215.2M
ROIC (23.35%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 7.75
(3.97%)
(45.44%)
Hold 11|5|8|0|5
2Q26
3Q26
4Q26
1Q27
Earnings per sharekr
0.11
0.11
0.11
0.11
10.87%
(1.81%)
(1.15%)
(9.89%)
Revenuekr M
22.18
22.35
22.64
23.00
1.50%
2.87%
0.40%
4.04%
Peers (US$21.76M)
Cap (US$)
PE
25.86M
—
20.82M
—
21.61M
—
Capital
TTM
5Y
10Y
Leveragex
1.532
0.371
0.345
EBIT/Intx
2.116
0.528
0.536
Own earn%
66.07
53.36
48.22
Sh yield%
28.49
31.98
32.32
Owners
Insiders/Inst%
2.46
38.64
Short interest%
2.55
SBC / revenue%
2.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
13–18
$1 testx
−0.1
Incr. ROIC%
2